main-logo

ICD-10 Code E09.3513 | Drug/chem diab with prolif diab rtnop with macular edema, bi Symptoms, Diagnosis, Billing

Drug or chemical-induced diabetes mellitus can lead to proliferative diabetic retinopathy with macular edema, particularly in both eyes. This condition arises from the toxic effects of certain medications or chemicals on insulin production or action, resulting in hyperglycemia and subsequent retinal complications. Accurate coding with ICD-10 Code E09.3513 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious complication.

What is ICD-10 Code E09.3513 for Drug/chem diab with prolif diab rtnop with macular edema, bi?

ICD-10 Code E09.3513 represents drug or chemical-induced diabetes mellitus with proliferative diabetic retinopathy and macular edema in both eyes. This code should be used when documenting cases where diabetes is a direct result of pharmacological agents, leading to severe ocular complications. It is crucial for accurate clinical documentation and billing, particularly in cases requiring specialized ophthalmological care.

ICD-10 Code E09.3513 – Clinical Definition and Explanation of Drug/chem diab with prolif diab rtnop with macular edema, bi

Drug or chemical-induced diabetes mellitus can progress to proliferative diabetic retinopathy with macular edema, necessitating urgent medical intervention. This condition is often caused by medications that impair insulin secretion or action, leading to chronic hyperglycemia and retinal damage. Early detection and management are critical to prevent vision loss.

Key Clinical Features:

  • Proliferative diabetic retinopathy characterized by neovascularization.
  • Macular edema leading to blurred or distorted vision.
  • History of drug or chemical exposure linked to diabetes onset.
  • Symptoms may include visual disturbances and difficulty in color perception.

ICD-10 Code E09.3513 for Drug/chem diab with prolif diab rtnop with macular edema, bi – SOAP Notes & Clinical Use

ICD-10 Code E09.3513 is utilized in SOAP notes to document the presence of drug-induced diabetes with associated ocular complications. It plays a vital role in capturing patient symptoms, assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.

What Does ICD-10 Code E09.3513 for Drug/chem diab with prolif diab rtnop with macular edema, bi Mean in SOAP Notes?

In SOAP notes, ICD-10 Code E09.3513 connects subjective patient reports and objective clinical findings to a formal diagnosis of drug-induced diabetes with proliferative retinopathy. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code E09.3513 – Drug/chem diab with prolif diab rtnop with macular edema, bi

Management of Drug/chem diab with prolif diab rtnop with macular edema, bi requires a multifaceted approach, focusing on glycemic control and ocular health.

Antibiotic Therapy:

  • Not applicable as this condition is not infectious.

Supportive Care:

  • Regular ophthalmologic evaluations to monitor retinal changes.
  • Management of blood glucose levels through dietary modifications and insulin therapy.
  • Laser photocoagulation for proliferative retinopathy.

Infection Control:

  • N/A for this non-infectious condition.

How to Document Symptoms of Drug/chem diab with prolif diab rtnop with macular edema, bi (ICD-10 E09.3513) in SOAP Notes

Subjective:

  • Patient reports blurred vision and difficulty seeing at night.
  • History of recent medication changes leading to increased blood sugar levels.
  • Complaints of seeing floaters or flashes of light in vision.
  • Patient expresses concern about potential vision loss.

Objective:

  • Visual acuity testing shows decreased vision in both eyes.
  • Fundoscopic examination reveals neovascularization and macular edema.
  • Blood glucose levels are elevated, indicating poor glycemic control.
  • Retinal imaging confirms the presence of proliferative diabetic retinopathy.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Drug/chem diab with prolif diab rtnop with macular edema, bi (ICD-10 Code E09.3513)

Assessment:

  • Diagnosis: Drug-induced diabetes mellitus with proliferative diabetic retinopathy and macular edema, bilateral.
  • ICD-10 Subcode: E09.3513.
  • Contributing factors include recent exposure to medications known to affect glucose metabolism.
  • Severity classified as moderate to severe due to retinal complications.

Plan:

  • Initiate insulin therapy to achieve glycemic control.
  • Refer to ophthalmology for evaluation and potential laser treatment.
  • Educate the patient on dietary management and blood sugar monitoring.
  • Schedule follow-up appointments to assess treatment efficacy and retinal health.

Treatment & Plan Section for ICD-10 Code E09.3513 – Drug/chem diab with prolif diab rtnop with macular edema, bi

  • First-line pharmacologic treatment includes insulin therapy to manage hyperglycemia.
  • Non-pharmacologic strategies involve dietary changes and regular exercise.
  • Monitoring practices include regular blood glucose checks and ophthalmologic assessments.
  • Follow-up care should be scheduled every 3-6 months to monitor retinal health.

Using ICD-10 Code E09.3513 for Drug/chem diab with prolif diab rtnop with macular edema, bi in Billing & SOAP Note Compliance

  • Select accurate subcodes based on the severity of retinopathy and diabetes management.
  • Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
  • Ensure treatment plans align with clinical guidelines to support justified billing.
  • Commonly billed CPT codes include 99214 for established patient visits and 92014 for ophthalmologic evaluations.

ICD-10 Code E09.3513 in Medical Billing and Insurance for Drug/chem diab with prolif diab rtnop with macular edema, bi

ICD-10 Code E09.3513 is critical in medical billing, particularly in hospital, ER, or specialty care settings for diabetes-related complications.

Billing Notes:

  • Ensure documentation includes specific drug exposure history to support the diagnosis.
  • Use this code in conjunction with appropriate CPT codes for comprehensive billing.
  • Document all relevant clinical findings to justify the use of this specific ICD-10 code.
  • Maintain accurate records of treatment plans and patient progress for audits.

Common CPT Pairings:

CPT CodeDescription
99214Established patient office visit, moderate complexity.
92014Ophthalmologic examination, comprehensive, established patient.
67028Laser photocoagulation for diabetic retinopathy.
83036Hemoglobin A1c test for diabetes management.

Frequently Asked Questions

Common Questions About Using ICD-10 Code E09.3513 for Drug/chem diab with prolif diab rtnop with macular edema, bi

What medications can cause drug-induced diabetes?

Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can induce diabetes by affecting insulin secretion or action, leading to hyperglycemia.

How is proliferative diabetic retinopathy diagnosed?

Proliferative diabetic retinopathy is diagnosed through comprehensive eye examinations, including fundoscopic exams and retinal imaging, which reveal neovascularization and macular edema.

What are the treatment options for diabetic retinopathy?

Treatment options include laser photocoagulation, anti-VEGF injections, and managing blood glucose levels to prevent progression of retinopathy.

Is hospitalization required for this condition?

Hospitalization may be necessary for severe cases of diabetic retinopathy or when complications arise, such as significant vision loss or uncontrolled diabetes.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved